Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Journal of the Neurological Sciences|January 10, 2013
Immunotherapy against amyloid pathology in Alzheimer's diseaseDaniela Galimberti, Laura Ghezzi, Elio ScarpiniDrug Design, Development and Therapy|December 20, 2013
Disease-modifying drugs in Alzheimer's diseaseLaura Ghezzi, Elio Scarpini, Daniela GalimbertiBiomedicines|July 27, 2022
The Gut Microbiome-Brain Crosstalk in Neurodegenerative DiseasesLaura Ghezzi, Claudia Cantoni, Emanuela Rotondo, et al.The Journal of Experimental Medicine|January 8, 2021
Effects of dietary restriction on neuroinflammation in neurodegenerative diseasesLuigi Fontana, Laura Ghezzi, Anne H Cross, et al.Multiple Sclerosis and Related Disorders|June 26, 2023
Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patientsClaudia Cantoni, Laura Ghezzi, Jasmine Choi, et al.The Journal of Clinical Investigation|July 1, 2021
Targeting the gut to treat multiple sclerosisLaura Ghezzi, Claudia Cantoni, Gabriela V Pinget, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 16, 2021
The influence of hormonal contraception on depression and female sexuality: a narrative review of the literatureLaura Buggio, Giussy Barbara, Federica Facchin, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 8, 2023
Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous SystemLaura Ghezzi, Bryan Bollman, Luca De Feo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2019
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patientsLaura Ghezzi, Claudia Cantoni, Francesca Cignarella, et al.Multiple Sclerosis and Related Disorders|January 20, 2025
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severityMiguel Tolentino, Francesca Pace, Dana C Perantie, et al.Pageof 7